Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Neratinib> ?p ?o. }
Showing items 1 to 77 of
77
with 100 items per page.
- Neratinib abstract "Neratinib (HKI-272) is a tyrosine kinase inhibitor under investigation for the treatment breast cancer and other solid tumours.It is in development for the treatment of early- and late-stage HER2-positive breast cancer.Like lapatinib and afatinib, it is a dual inhibitor of the human epidermal growth factor receptor 2 (Her2) and epidermal growth factor receptor (EGFR) kinases.".
- Neratinib atcPrefix "none".
- Neratinib casNumber "698387-09-6".
- Neratinib fdaUniiCode "JJH94R3PWB".
- Neratinib iupacName "(2E)-N-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide".
- Neratinib pubchem "9915743".
- Neratinib thumbnail Neratinib_skeletal.svg?width=300.
- Neratinib wikiPageID "20505556".
- Neratinib wikiPageRevisionID "592628146".
- Neratinib atcPrefix "none".
- Neratinib c "30".
- Neratinib casNumber "698387".
- Neratinib chembl "180022".
- Neratinib chemspiderid "8091392".
- Neratinib cl "1".
- Neratinib h "29".
- Neratinib hasPhotoCollection Neratinib.
- Neratinib iupacName "-N-[4-[[3-chloro-4-[methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-but-2-enamide".
- Neratinib kegg "D08950".
- Neratinib molecularWeight "557.04".
- Neratinib n "6".
- Neratinib o "3".
- Neratinib pubchem "9915743".
- Neratinib routesOfAdministration "Oral".
- Neratinib smiles "O=CNc4cc1ccc4OCC".
- Neratinib stdinchi "1".
- Neratinib stdinchikey "JWNPDZNEKVCWMY-VQHVLOKHSA-N".
- Neratinib unii "JJH94R3PWB".
- Neratinib verifiedfields "changed".
- Neratinib verifiedrevid "462259601".
- Neratinib subject Category:Alkenes.
- Neratinib subject Category:Amides.
- Neratinib subject Category:Aromatic_amines.
- Neratinib subject Category:Nitriles.
- Neratinib subject Category:Organochlorides.
- Neratinib subject Category:Phenol_ethers.
- Neratinib subject Category:Pyridines.
- Neratinib subject Category:Quinolines.
- Neratinib subject Category:Receptor_tyrosine_kinase_inhibitors.
- Neratinib type Abstraction100002137.
- Neratinib type AliphaticCompound114601294.
- Neratinib type Alkene114713120.
- Neratinib type Alkenes.
- Neratinib type Amide114724264.
- Neratinib type Amides.
- Neratinib type Amine114739004.
- Neratinib type AromaticAmines.
- Neratinib type Base114618253.
- Neratinib type Chemical114806838.
- Neratinib type Compound114818238.
- Neratinib type Element114840755.
- Neratinib type Material114580897.
- Neratinib type Matter100020827.
- Neratinib type MethaneSeries114951377.
- Neratinib type Nitrile114827346.
- Neratinib type Nitriles.
- Neratinib type OrganicCompound114727670.
- Neratinib type Part113809207.
- Neratinib type PhenolEthers.
- Neratinib type PhysicalEntity100001930.
- Neratinib type Pyridine114692510.
- Neratinib type Pyridines.
- Neratinib type Quintessence114847103.
- Neratinib type Relation100031921.
- Neratinib type Substance100019613.
- Neratinib type Drug.
- Neratinib type DrugProduct.
- Neratinib type FunctionalSubstance.
- Neratinib comment "Neratinib (HKI-272) is a tyrosine kinase inhibitor under investigation for the treatment breast cancer and other solid tumours.It is in development for the treatment of early- and late-stage HER2-positive breast cancer.Like lapatinib and afatinib, it is a dual inhibitor of the human epidermal growth factor receptor 2 (Her2) and epidermal growth factor receptor (EGFR) kinases.".
- Neratinib label "Neratinib".
- Neratinib sameAs m.04zwl3b.
- Neratinib sameAs Q6995920.
- Neratinib sameAs Q6995920.
- Neratinib sameAs Neratinib.
- Neratinib wasDerivedFrom Neratinib?oldid=592628146.
- Neratinib depiction Neratinib_skeletal.svg.
- Neratinib isPrimaryTopicOf Neratinib.